Protection of mesenchymal stem cells on acute kidney injury

Zhao,Jing‑Jie; Liu,Jun‑Li; Liu,Ling; Jia,Hong‑Ying

doi:10.3892/mmr.2013.1792

Protection of mesenchymal stem cells on acute kidney injury

Authors:
- Jing‑Jie Zhao
- Jun‑Li Liu
- Ling Liu
- Hong‑Ying Jia
View Affiliations

Affiliations: Clinical Molecular Biology Laboratory, The Second Hospital of Shandong University, Jinan, Shandong 250033, P.R. China
Published online on: November 12, 2013 https://doi.org/10.3892/mmr.2013.1792
Pages: 91-96

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to determine the protection of allogeneic bone marrow mesenchymal stem cells (BMSCs) on an ischaemia/reperfusion (I/R)‑induced acute kidney injury (AKI) rat model and to investigate the underlying mechanisms. The BMSCs were isolated and cultured from adult Sprague‑Dawley (SD) rats and the I/R‑induced AKI model was established by bilateral clamping of renal pedicles for 60 min. Following successfully establishing the AKI model, 1x106 BMSCs were administered by intrarenal injection. All animals were randomly divided into four groups (n=10 in each): 1 (sham control), 2 (I/R), 3 (I/R + culture medium) and 4 (I/R + BMSCs). Serum levels of creatinine (Cr) and blood urea nitrogen (BUN) were measured in all four groups at 24 and 72 h. Three days post‑surgery, the level of inflammatory factors, including interleukin‑6 (IL‑6), tumour necrosis factor‑α (TNF‑α) and vascular endothelial growth factor (VEGF) in the kidney was analysed by quantitative polymerase chain reaction. Three days following surgery, mRNA expression levels of IL‑6 and TNF‑α were significantly lower, however, the expression level of VEGF was significantly higher in group 4 compared with groups 2 and 3 (P<0.05). By contrast, the immunofluorescence results showed that the injected BMSCs differentiated into vascular endothelial cells. In conclusion, the present study identified that intrarenal administration of BMSCs improved I/R‑induced AKI through the anti‑inflammatory effect and a paracrine mechanism and therefore, may be hypothesised for the use in clinical trials.

View Figures

View References

1	Webb S and Dobb G: ARF, ATN or AKI? It’s now acute kidney injury. Anaesth Intensive Care. 35:843–844. 2007.
2	Garcia-Tsao G, Parikh CR and Viola A: Acute kidney injury in cirrhosis. Hepatology. 48:2064–2077. 2008. View Article : Google Scholar
3	Sáenz-Morales D, Escribese MM, Stamatakis K, García-Martos M, Alegre L, Conde E, Pérez-Sala D, Mampaso F and García-Bermejo ML: Requirements for proximal tubule epithelial cell detachment in response to ischemia: role of oxidative stress. Exp Cell Res. 312:3711–3727. 2006.PubMed/NCBI
4	Thurman JM: Triggers of inflammation after renal ischemia/reperfusion. Clin Immunol. 123:7–13. 2007. View Article : Google Scholar : PubMed/NCBI
5	Boros P and Bromberg JS: New cellular and molecular immune pathways in ischemia/reperfusion injury. Am J Transplant. 6:652–658. 2006. View Article : Google Scholar : PubMed/NCBI
6	Gupta S, Verfaillie C, Chmielewski D, et al: Isolation and characterization of kidney-derived stem cells. J Am Soc Nephrol. 17:3028–3040. 2006. View Article : Google Scholar : PubMed/NCBI
7	Chen YT, Sun CK, Lin YC, et al: Adipose-derived mesenchymal stem cell protects kidneys against ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction. J Transl Med. 9:512011. View Article : Google Scholar
8	Li B, Cohen A, Hudson TE, Motlagh D, Amrani DL and Duffield JS: Mobilized human hematopoietic stem/progenitor cells promote kidney repair after ischemia/reperfusion injury. Circulation. 121:2211–2220. 2010. View Article : Google Scholar : PubMed/NCBI
9	Bi B, Schmitt R, Israilova M, Nishio H and Cantley LG: Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol. 18:2486–2496. 2007. View Article : Google Scholar : PubMed/NCBI
10	Yip HK, Chang LT, Wu CJ, Sheu JJ, Youssef AA, Pei SN, Lee FY and Sun CK: Autologous bone marrow-derived mononuclear cell therapy prevents the damage of viable myocardium and improves rat heart function following acute anterior myocardial infarction. Circ J. 72:1336–1345. 2008. View Article : Google Scholar : PubMed/NCBI
11	Dekel B, Shezen E, Even-Tov-Friedman S, Katchman H, Margalit R, Nagler A and Reisner Y: Transplantation of human hematopoietic stem cells into ischemic and growing kidneys suggests a role in vasculogenesis but not tubulogenesis. Stem Cells. 24:1185–1193. 2006. View Article : Google Scholar : PubMed/NCBI
12	Szczypka MS, Westover AJ, Clouthier SG, Ferrara JL and Humes HD: Rare incorporation of bone marrow-derived cells into kidney after folic acid-induced injury. Stem Cells. 23:44–54. 2005. View Article : Google Scholar : PubMed/NCBI
13	Sutton TA, Kelly KJ, Mang HE, Plotkin Z, Sandoval RM and Dagher PC: Minocycline reduces renal microvascular leakage in a rat model of ischemic renal injury. Am J Physiol Renal Physiol. 288:F91–F97. 2005. View Article : Google Scholar : PubMed/NCBI
14	Gao J, Dennis JE, Muzic RF, Lundberg M and Caplan AI: The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs. 169:12–20. 2001. View Article : Google Scholar : PubMed/NCBI
15	Nagaya N, Fujii T, Iwase T, Ohgushi H, Itoh T, Uematsu M, Yamagishi M, Mori H, Kangawa K and Kitamura S: Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol. 287:H2670–H2676. 2004. View Article : Google Scholar
16	Luan Y, Zhang ZH, Wei DE, Lu Y and Wang YB: Effects of autologous bone marrow mononuclear cells implantation in canine model of pulmonary hypertension. Circ J. 76:977–985. 2012. View Article : Google Scholar : PubMed/NCBI
17	Semedo P, Palasio CG, Oliveira CD, et al: Early modulation of inflammation by mesenchymal stem cell after acute kidney injury. Int Immunopharmacol. 9:677–682. 2009. View Article : Google Scholar : PubMed/NCBI
18	Infanger M, Kossmehl P, Shakibaei M, et al: Induction of three-dimensional assembly and increase in apoptosis of human endothelial cells by simulated microgravity: Impact of vascular endothelial growth factor. Apoptosis. 11:749–764. 2006. View Article : Google Scholar
19	Sementilli A and Franco M: Renal acute cellular rejection: correlation between the immunophenotype and cytokine expression of the inflammatory cells in acute glomerulitis, arterial intimitis, and tubulointerstitial nephritis. Transplant Proc. 42:1671–1676. 2010. View Article : Google Scholar
20	Ali T, Khan I, Simpson W, Prescott G, Townend J, Smith W and Macleod A: Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol. 18:1292–1298. 2007. View Article : Google Scholar : PubMed/NCBI
21	Grossini E, Molinari C, Pollesello P, Bellomo G, Valente G, Mary D, Vacca G and Caimmi P: Levosimendan protection against kidney ischemia/reperfusion injuries in anesthetized pigs. J Pharmacol Exp Ther. 342:376–388. 2012. View Article : Google Scholar : PubMed/NCBI
22	Lafrance JP and Miller DR: Acute kidney injury associates with increased long-term mortality. J Am Soc Nephrol. 21:345–352. 2010. View Article : Google Scholar : PubMed/NCBI
23	da Silva LB, Palma PV, Cury PM and Bueno V: Evaluation of stem cell administration in a model of kidney ischemia-reperfusion injury. Int Immunopharmacol. 15:1609–1616. 2007.PubMed/NCBI
24	Bonventre JV and Zuk A: Ischemic acute renal failure: an inflammatory disease? Kidney Int. 66:480–485. 2004. View Article : Google Scholar : PubMed/NCBI
25	Li H and Nord EP: CD40 ligation stimulates MCP-1 and IL-8 production, TRAF6 recruitment, and MAPK activation in proximal tubule cells. Am J Physiol Renal Physiol. 282:F1020–F1033. 2002.PubMed/NCBI
26	Deng J, Kohda Y, Chiao H, Wang Y, Hu X, Hewitt SM, Miyaji T, McLeroy P, Nibhanupudy B, Li S and Star RA: Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury. Kidney Int. 60:2118–2128. 2001. View Article : Google Scholar : PubMed/NCBI
27	Imberti B, Morigi M, Tomasoni S, et al: Insulin-like growth factor-1 sustains stem cell mediated renal repair. J Am Soc Nephrol. 18:2921–2928. 2007. View Article : Google Scholar : PubMed/NCBI
28	Tögel F, Weiss K, Yang Y, Hu Z, Zhang P and Westenfelder C: Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol. 292:F1626–F1635. 2007.PubMed/NCBI
29	Bussolati B, Tetta C and Camussi G: Contribution of stem cells to kidney repair. Am J Nephrol. 28:813–822. 2008. View Article : Google Scholar : PubMed/NCBI
30	Yuan L, Wu MJ, Sun HY, Xiong J, Zhang Y, Liu CY, Fu LL, Liu DM, Liu HQ and Mei CL: VEGF-modified human embryonic mesenchymal stem cell implantation enhances protection against cisplatin-induced acute kidney injury. Am J Physiol Renal Physiol. 300:F207–F218. 2011. View Article : Google Scholar : PubMed/NCBI
31	Hiroyoshi T, Tsuchida M, Uchiyama K, Fujikawa K, Komatsu T, Kanaoka Y and Matsuyama H: Splenectomy protects the kidneys against ischemic reperfusion injury in the rat. Transpl Immunol. 27:8–11. 2012. View Article : Google Scholar : PubMed/NCBI
32	Morigi M, Introna M, Imberti B, et al: Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells. 26:2075–2082. 2008. View Article : Google Scholar : PubMed/NCBI
33	Hagiwara M, Shen B, Chao L and Chao J: Kallikrein-modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation. Hum Gene Ther. 19:807–819. 2008. View Article : Google Scholar
34	Hoste EA and Schurgers M: Epidemiology of acute kidney injury: how big is the problem? Crit Care Med. 36(Suppl 4): S146–S151. 2008. View Article : Google Scholar : PubMed/NCBI